Cargando…

Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV

Few studies have examined preventative behaviour practices with respect to COVID-19 among people living with HIV (human immunodeficiency virus). Using a cross-sectional survey from a Canadian Institutes of Health Research Canadian HIV Trials Network study (CTN 328) of people living with HIV on vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammond, Keely, Lee, Terry, Vulesevic, Branka, Singer, Joel, Needham, Judy, Burchell, Ann N., Samji, Hasina, Walmsley, Sharon, Hull, Mark, Jenabian, Mohammad-Ali, Routy, Jean-Pierre, Margolese, Shari, Mandarino, Enrico, Anis, Aslam H., Cooper, Curtis L., Costiniuk, Cecilia T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588118/ https://www.ncbi.nlm.nih.gov/pubmed/37858245 http://dx.doi.org/10.1186/s12981-023-00571-7

Ejemplares similares

Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey
por: Costiniuk, Cecilia T., et al.
Publicado: (2023)

Antibody neutralization capacity after coronavirus disease 2019 vaccination in people with HIV in Canada
por: Costiniuk, Cecilia T., et al.
Publicado: (2023)

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

COVID-19 vaccine immunogenicity in people with HIV
por: Costiniuk, Cecilia T., et al.
Publicado: (2023)

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
por: Costiniuk, Cecilia T, et al.
Publicado: (2019)

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2023)

Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design
por: Fowokan, Adeleke, et al.
Publicado: (2023)

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)
por: Alexandrova, Yulia, et al.
Publicado: (2023)

COVID‐19 vaccine effectiveness by HIV status and history of injection drug use: a test‐negative analysis
por: Puyat, Joseph H., et al.
Publicado: (2023)

Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV
por: Chambers, Catharine, et al.
Publicado: (2022)

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review
por: Wright, Patrick, et al.
Publicado: (2020)

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort
por: Tanner, Zachary, et al.
Publicado: (2016)

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
por: Costiniuk, Cecilia, et al.
Publicado: (2023)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
por: Costiniuk, Cecilia T., et al.
Publicado: (2020)

Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals
por: Moqueet, Nasheed, et al.
Publicado: (2015)

Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
por: Cinque, Felice, et al.
Publicado: (2023)

Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting
por: Milloy, M-J, et al.
Publicado: (2016)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
por: Alexandrova, Yulia, et al.
Publicado: (2022)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2016)

2.69 Age Group–Specific Determinants of Mental Illness and Unmet Support Needs Among Canadians After the First COVID-19 Wave
por: Stewart, S. Evelyn, et al.
Publicado: (2022)

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults
por: Hull, Mark, et al.
Publicado: (2014)

Gay, bisexual, and other men who have sex with men accessing STI clinics: Optimizing HIV PrEP implementation
por: Samji, Hasina, et al.
Publicado: (2022)

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
por: Rossi, Carmine, et al.
Publicado: (2017)

Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study
por: Cescon, Angela, et al.
Publicado: (2013)

Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
por: Patterson, Sophie, et al.
Publicado: (2015)

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection
por: Mehraj, Vikram, et al.
Publicado: (2016)

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment
por: Hull, Mark, et al.
Publicado: (2016)

Age-specific determinants of psychiatric outcomes after the first COVID-19 wave: baseline findings from a Canadian online cohort study
por: Stewart, S. Evelyn, et al.
Publicado: (2023)

HIV persistence in mucosal CD4(+) T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies
por: Bansback, Nick, et al.
Publicado: (2012)

Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Costiniuk, Cecilia T., et al.
Publicado: (2016)

Cannabinoids and Chronic Liver Diseases
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence
por: Darwish, Ilyse, et al.
Publicado: (2021)

Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator?
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cn70986andnl7c6r01t5m8n1pu